328 related articles for article (PubMed ID: 37109715)
21. In young patients with Turner or Down syndrome, Graves' disease presentation is often preceded by Hashimoto's thyroiditis.
Aversa T; Lombardo F; Corrias A; Salerno M; De Luca F; Wasniewska M
Thyroid; 2014 Apr; 24(4):744-7. PubMed ID: 24325626
[TBL] [Abstract][Full Text] [Related]
22. A Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination.
Taşkaldıran I; Altay FP; Bozkuş Y; İyidir ÖT; Nar A; Tütüncü NB
Endocr Metab Immune Disord Drug Targets; 2023; 23(3):405-409. PubMed ID: 35713143
[TBL] [Abstract][Full Text] [Related]
23. Development of Grave's disease seven months after Hashimoto's thyroiditis: a rare occurrence.
Bravo-Llerena WE; Valderrabano-Wagner RJ; Quevedo-Quevedo J; Reyes-Ortiz LM
Bol Asoc Med P R; 2010; 102(3):76-8. PubMed ID: 23875526
[TBL] [Abstract][Full Text] [Related]
24. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
25. [A case of Hypothyroid Graves' disease with extremely high titers of TSAb].
Nakai M; Okada Y; Tanikawa T; Kanda K; Morita E; Tanaka Y
J UOEH; 2003 Sep; 25(3):333-9. PubMed ID: 14503045
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of COVID-19 and autoimmune thyroiditis.
Tutal E; Ozaras R; Leblebicioglu H
Travel Med Infect Dis; 2022; 47():102314. PubMed ID: 35307540
[TBL] [Abstract][Full Text] [Related]
27. Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
Nishihara E; Amino N; Kudo T; Ito M; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Endocr J; 2017 Oct; 64(10):955-961. PubMed ID: 28768936
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.
Boelaert K; Newby PR; Simmonds MJ; Holder RL; Carr-Smith JD; Heward JM; Manji N; Allahabadia A; Armitage M; Chatterjee KV; Lazarus JH; Pearce SH; Vaidya B; Gough SC; Franklyn JA
Am J Med; 2010 Feb; 123(2):183.e1-9. PubMed ID: 20103030
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
30. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease.
Rayman MP
Proc Nutr Soc; 2019 Feb; 78(1):34-44. PubMed ID: 30208979
[TBL] [Abstract][Full Text] [Related]
31. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
Sato H
Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139
[TBL] [Abstract][Full Text] [Related]
33. Conversion of autoimmune hypothyroidism to hyperthyroidism.
Furqan S; Haque NU; Islam N
BMC Res Notes; 2014 Aug; 7():489. PubMed ID: 25086829
[TBL] [Abstract][Full Text] [Related]
34. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.
Rieu M; Richard A; Rosilio M; Laplanche S; Ropion V; Fombeur JP; Berrod JL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):529-35. PubMed ID: 8187321
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
36. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.
Shigemasa C; Mitani Y; Taniguchi S; Adachi T; Ueta Y; Urabe K; Miyazaki S; Tanaka T; Yoshida A; Mashiba H
Arch Intern Med; 1990 May; 150(5):1105-9. PubMed ID: 1691909
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune switch from hyperthyroidism to hypothyroidism in Graves' disease.
Padmanaban P; Jain R
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148577
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune thyroid diseases as a cost of physiological autoimmune surveillance.
Milo T; Korem Kohanim Y; Toledano Y; Alon U
Trends Immunol; 2023 May; 44(5):365-371. PubMed ID: 37061365
[TBL] [Abstract][Full Text] [Related]
39. A case of Hashimoto's thyroiditis following Graves' disease.
Oueslati I; Salhi S; Yazidi M; Chaker F; Chihaoui M
Clin Case Rep; 2022 Oct; 10(10):e6466. PubMed ID: 36254153
[TBL] [Abstract][Full Text] [Related]
40. Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves' disease: case report.
Elsherbiny TM
Ther Adv Endocrinol Metab; 2024; 15():20420188241256470. PubMed ID: 38808008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
